Article
An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19.
European journal of clinical pharmacology - 1 May 2001
Tamminga W J, Wemer J, Oosterhuis B, Brakenhoff J P, Gerrits M G, de Zeeuw R A, de Leij L F, Jonkman J H
Abstract excerpt
A method for simultaneous phenotyping and genotyping for CYP2D6 and CYP2C19 was tested. Six healthy volunteers were selected (three extensive and three poor metabolisers for CYP2D6). CYP2D6 was probed with dextromethorphan and metoprolol and CYP2C19 was probed with omeprazole. Blood samples were collected and analysed for dextromethorphan, dextrorphan, metoprolol, alpha-hydroxymetoprol, omeprazole and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
